ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours.
about
Current Stem Cell Biomarkers and Their Functional Mechanisms in Prostate CancerTargeted therapy of gastrointestinal stromal tumoursEmerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future DirectionsPersonalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA AnalysisEvolution of the cancer genomeEGFR/Ras Signaling Controls Drosophila Intestinal Stem Cell Proliferation via Capicua-Regulated GenesImatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skinPlakophilin-3 catenin associates with the ETV1/ER81 transcription factor to positively modulate gene activityStructures of the Ets Protein DNA-binding Domains of Transcription Factors Etv1, Etv4, Etv5, and Fev: DETERMINANTS OF DNA BINDING AND REDOX REGULATION BY DISULFIDE BOND FORMATION.Large-scale quality analysis of published ChIP-seq data.An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.Transcription factor Etv5 is essential for the maintenance of alveolar type II cells.Targeted therapy for cancer: the gastrointestinal stromal tumor model.Anti-apoptotic effects of osteopontin through the up-regulation of Mcl-1 in gastrointestinal stromal tumors.Investigation of the effective action distance between hematopoietic stem/progenitor cells and human adipose-derived stem cells during their in vitro co-culture.C-KIT signaling depends on microphthalmia-associated transcription factor for effects on cell proliferationExpression of a neuroendocrine gene signature in gastric tumor cells from CEA 424-SV40 large T antigen-transgenic mice depends on SV40 large T antigen.A small molecule that binds and inhibits the ETV1 transcription factor oncoproteinMolecular pathways: targeting ETS gene fusions in cancer.Updates on the management of gastrointestinal stromal tumors.Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST).TMPRSS2- driven ERG expression in vivo increases self-renewal and maintains expression in a castration resistant subpopulationThe ETS family of oncogenic transcription factors in solid tumours.Gastrointestinal stromal tumor - an evolving concept.Gene expression network analysis of ETV1 reveals KCTD10 as a novel prognostic biomarker in gastrointestinal stromal tumor.PEA3/ETV4-related transcription factors coupled with active ERK signalling are associated with poor prognosis in gastric adenocarcinoma.Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug ResistanceGeneralized neuromuscular hypoplasia, reduced smooth muscle myosin and altered gut motility in the klotho model of premature agingCD117⁺ cells in the circulation are predictive of advanced prostate cancerCOP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer.Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells.Association of high expression of Groβ with clinical and pathological characteristics of unfavorable prognosis in gastrointestinal stromal tumors.Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer.Either Kras activation or Pten loss similarly enhance the dominant-stable CTNNB1-induced genetic program to promote granulosa cell tumor development in the ovary and testis.Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia.Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido.Targeting Disease Persistence in Gastrointestinal Stromal TumorsPlatelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.LRIG1 Regulates Ontogeny of Smooth Muscle-Derived Subsets of Interstitial Cells of Cajal in Mice.Advances in sarcoma genomics and new therapeutic targets.
P2860
Q26742062-FABB544C-2DD6-46FA-8A64-614B68DAA6B1Q26745633-863DA46F-099F-4343-A1A6-57EE9D18E6E6Q26799387-08BD8D4E-B73B-419F-9683-9C029A9F1F84Q26800005-12292517-3254-4DCF-A6F8-5C40FFA5C934Q27020991-22854811-A3AC-44E4-BBB1-F4FE47406B26Q27310105-CB75F0A2-EB0E-49BD-9032-15BC95541274Q27852360-E395ECA2-F969-47C8-B5BE-FCDC3CD514DFQ28539201-D30CAAD1-75BC-40D5-A2E7-5743448482C8Q30373611-064FBE46-268E-4F82-AD86-BC47ECE932F5Q30717456-D6D425F6-7EFA-4EF2-ACE3-9D9D6A852737Q33274526-EBE3FEDB-46B9-4F8F-82E9-B2512208311EQ33569337-F8F621A4-6F90-405E-9507-8E8638F925F2Q33807742-D2966780-42BB-44D6-8E87-6DC17E4CBF3AQ33841673-10A3FCEE-8694-4014-8C60-2C441585F51CQ33925418-B65E65DE-723C-4A90-9A29-C86E2D07A571Q34009824-E3B9915A-37F1-4575-9587-741DFEBE4677Q34130710-1A925C27-15F8-4978-AB72-BF58FBAB9156Q34132931-D1E97947-431F-4F69-9729-2245577F09CAQ34135434-D6BFF94C-8563-4BF6-B156-C5E49CFD7327Q34256921-3636391A-A455-47EE-8109-D4D0A1C496FEQ34274467-F1CD2333-A7CF-4D8D-A093-E99408CC4784Q34364174-DBEA3982-1D2D-4811-AD50-5501334D66D1Q34555986-3A6CAE23-1353-4A00-BE90-03E64E5BAD2FQ34928165-87CDBD01-2ADD-4CF0-8860-99BF736399B4Q34974255-3863F239-6C65-4FDF-979C-1F170C0DCBF4Q35108347-E6D768DF-F0B1-4BF6-822C-E5C734460FC8Q35143027-85FFBB55-47FA-481D-8DAF-93B0DF143E97Q35145773-03261F0B-6C9F-43F1-A037-3F0EBA010F90Q35176469-15D69815-D561-4B6F-BFA0-62654A33C4AEQ35237824-4E561292-E618-4623-BDAE-E1DCFDC6B311Q35493982-4B141847-F5F2-4946-995E-E1D698FB7420Q35511907-BD18CAEE-DD1A-48EC-8B68-B7DA50C63642Q35550192-34484F12-1C42-42DD-9A94-1ECA3CA9E1C0Q35571685-CE5344D7-1BA6-4A7A-BEA0-D9553734C115Q35663219-6E179520-212B-46F4-90C6-B9C03473DC01Q35753251-897516D9-D311-4D63-9F7D-7E6E68ADA317Q35777530-09BF89A7-8A81-42A2-8EC1-F9AFC74E0D77Q35893568-F42E0D0E-93A6-47BE-8EA9-0F877CE211DDQ35923693-86AFA371-333C-4E58-B199-45C5274FC78FQ35993346-E53848F9-A995-4459-9F39-1E0C70B59254
P2860
ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
ETV1 is a lineage survival fac ...... trointestinal stromal tumours.
@en
ETV1 is a lineage survival fac ...... trointestinal stromal tumours.
@nl
type
label
ETV1 is a lineage survival fac ...... trointestinal stromal tumours.
@en
ETV1 is a lineage survival fac ...... trointestinal stromal tumours.
@nl
prefLabel
ETV1 is a lineage survival fac ...... trointestinal stromal tumours.
@en
ETV1 is a lineage survival fac ...... trointestinal stromal tumours.
@nl
P2093
P2860
P356
P1433
P1476
ETV1 is a lineage survival fac ...... trointestinal stromal tumours.
@en
P2093
C David Allis
Charles L Sawyers
Cristina R Antonescu
John Wongvipat
Jonathan A Fletcher
Scott Dewell
Tambudzai Shamu
Xingyi Guo
P2860
P2888
P304
P356
10.1038/NATURE09409
P407
P577
2010-10-03T00:00:00Z
P5875
P6179
1004547160